221 related articles for article (PubMed ID: 26503558)
21. Cucurbitacin mediated regulation of deregulated oncogenic signaling cascades and non-coding RNAs in different cancers: Spotlight on JAK/STAT, Wnt/β-catenin, mTOR, TRAIL-mediated pathways.
Lin X; Farooqi AA
Semin Cancer Biol; 2021 Aug; 73():302-309. PubMed ID: 33152487
[TBL] [Abstract][Full Text] [Related]
22. Euphorbia lunulata extract acts on multidrug resistant gastric cancer cells to inhibit cell proliferation, migration and invasion, arrest cell cycle progression, and induce apoptosis.
Fu Z; Han X; Du J; Han X; Liu W; Shao S; Liu X
J Ethnopharmacol; 2018 Feb; 212():8-17. PubMed ID: 28811220
[TBL] [Abstract][Full Text] [Related]
23. Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
Sun J; Blaskovich MA; Jove R; Livingston SK; Coppola D; Sebti SM
Oncogene; 2005 May; 24(20):3236-45. PubMed ID: 15735720
[TBL] [Abstract][Full Text] [Related]
24. Recent Advances in the Application of Cucurbitacins as Anticancer Agents.
Zieniuk B; Pawełkowicz M
Metabolites; 2023 Oct; 13(10):. PubMed ID: 37887406
[TBL] [Abstract][Full Text] [Related]
25. Cucurbitacin B: A review of its pharmacology, toxicity, and pharmacokinetics.
Dai S; Wang C; Zhao X; Ma C; Fu K; Liu Y; Peng C; Li Y
Pharmacol Res; 2023 Jan; 187():106587. PubMed ID: 36460279
[TBL] [Abstract][Full Text] [Related]
26. Cucurbitacin IIb, a steroidal triterpene from Ibervillea sonorae induces antiproliferative and apoptotic effects on cervical and lung cancer cells.
Torres-Moreno H; Marcotullio MC; Velázquez C; Ianni F; Garibay-Escobar A; Robles-Zepeda RE
Steroids; 2020 May; 157():108597. PubMed ID: 32068079
[TBL] [Abstract][Full Text] [Related]
27. Cucurbitacin IIa interferes with EGFR-MAPK signaling pathway leads to proliferation inhibition in A549 cells.
Zhang J; Song Y; Liang Y; Zou H; Zuo P; Yan M; Jing S; Li T; Wang Y; Li D; Zhang T; Wei Z
Food Chem Toxicol; 2019 Oct; 132():110654. PubMed ID: 31265865
[TBL] [Abstract][Full Text] [Related]
28. Cucurbitacins inspired organic synthesis: Potential dual inhibitors targeting EGFR - MAPK pathway.
Mahnashi M; Elgazwi SM; Ahmed MS; Halaweish FT
Eur J Med Chem; 2019 Jul; 173():294-304. PubMed ID: 31022583
[TBL] [Abstract][Full Text] [Related]
29. Anticancer activity of grassy Hystrix brachyura bezoar and its mechanisms of action: An in vitro and in vivo based study.
Khan AYF; Ahmed QU; Narayanamurthy V; Razali S; Asuhaimi FA; Saleh MSM; Johan MF; Khatib A; Seeni A; Wahab RA
Biomed Pharmacother; 2019 Jun; 114():108841. PubMed ID: 30981106
[TBL] [Abstract][Full Text] [Related]
30. Apigenin: A dietary flavonoid with diverse anticancer properties.
Madunić J; Madunić IV; Gajski G; Popić J; Garaj-Vrhovac V
Cancer Lett; 2018 Jan; 413():11-22. PubMed ID: 29097249
[TBL] [Abstract][Full Text] [Related]
31. Zerumbone targets the CXCR4-RhoA and PI3K-mTOR signaling axis to reduce motility and proliferation of oral cancer cells.
Zainal NS; Gan CP; Lau BF; Yee PS; Tiong KH; Abdul Rahman ZA; Patel V; Cheong SC
Phytomedicine; 2018 Jan; 39():33-41. PubMed ID: 29433681
[TBL] [Abstract][Full Text] [Related]
32. Isolation of anticancer constituents from Cucumis prophetarum var. prophetarum through bioassay-guided fractionation.
Alsayari A; Kopel L; Ahmed MS; Soliman HSM; Annadurai S; Halaweish FT
BMC Complement Altern Med; 2018 Oct; 18(1):274. PubMed ID: 30301463
[TBL] [Abstract][Full Text] [Related]
33. Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors.
Molavi O; Ma Z; Mahmud A; Alshamsan A; Samuel J; Lai R; Kwon GS; Lavasanifar A
Int J Pharm; 2008 Jan; 347(1-2):118-27. PubMed ID: 17681440
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms underlying the anticancer activities of licorice flavonoids.
Zhang Z; Yang L; Hou J; Tian S; Liu Y
J Ethnopharmacol; 2021 Mar; 267():113635. PubMed ID: 33246112
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological studies of c(RGDyK) conjugates of cucurbitacins.
Chatzisideri T; Dalezis P; Leonidis G; Bousis S; Trafalis D; Bianchini F; Sarli V
Future Med Chem; 2021 May; 13(10):877-895. PubMed ID: 33858195
[TBL] [Abstract][Full Text] [Related]
36. Actin-aggregating cucurbitacins from Physocarpus capitatus.
Maloney KN; Fujita M; Eggert US; Schroeder FC; Field CM; Mitchison TJ; Clardy J
J Nat Prod; 2008 Nov; 71(11):1927-9. PubMed ID: 18959442
[TBL] [Abstract][Full Text] [Related]
37. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.
Xie J; Liu JH; Liu H; Liao XZ; Chen Y; Lin MG; Gu YY; Liu TL; Wang DM; Ge H; Mo SL
BMC Cancer; 2016 Nov; 16(1):899. PubMed ID: 27863471
[TBL] [Abstract][Full Text] [Related]
38. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X
Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357
[TBL] [Abstract][Full Text] [Related]
39. The cucurbitacins E, D and I: investigation of their cytotoxicity toward human chondrosarcoma SW 1353 cell line and their biotransformation in man liver.
Abbas S; Vincourt JB; Habib L; Netter P; Greige-Gerges H; Magdalou J
Toxicol Lett; 2013 Feb; 216(2-3):189-99. PubMed ID: 23194827
[TBL] [Abstract][Full Text] [Related]
40. Efficient extraction of cucurbitacins from Diplocyclos palmatus (L.) C. Jeffrey: Optimization using response surface methodology, extraction methods and study of some important bioactivities.
Patel SB; Attar UA; Sakate DM; Ghane SG
Sci Rep; 2020 Feb; 10(1):2109. PubMed ID: 32034276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
